Omnimmune Net Income Applicable To Common Shares from 2010 to 2025
| OMMH Stock | USD 0.0001 0.00 0.00% |
Net Loss | First Reported 2010-12-31 | Previous Quarter -1.6 M | Current Value -1.7 M | Quarterly Volatility 426.6 K |
Check Omnimmune Holdings financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Omnimmune Holdings' main balance sheet or income statement drivers, such as Interest Expense of 0.0, Selling General Administrative of 1.9 M or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 0.58, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. Omnimmune financial statements analysis is a perfect complement when working with Omnimmune Holdings Valuation or Volatility modules.
Omnimmune | Net Income Applicable To Common Shares | Build AI portfolio with Omnimmune Stock |
Currently Active Assets on Macroaxis
| DD | Dupont De Nemours | |
| CRDO | Credo Technology Group | |
| GOOG | Alphabet Inc Class C | |
| BAC | Bank of America | |
| CRM | Salesforce |
Check out the analysis of Omnimmune Holdings Correlation against competitors. For more detail on how to invest in Omnimmune Stock please use our How to Invest in Omnimmune Holdings guide.You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Omnimmune Holdings. If investors know Omnimmune will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Omnimmune Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Omnimmune Holdings is measured differently than its book value, which is the value of Omnimmune that is recorded on the company's balance sheet. Investors also form their own opinion of Omnimmune Holdings' value that differs from its market value or its book value, called intrinsic value, which is Omnimmune Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Omnimmune Holdings' market value can be influenced by many factors that don't directly affect Omnimmune Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Omnimmune Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Omnimmune Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Omnimmune Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.